Published in NMR Biomed on August 01, 2009
Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry (2010) 2.08
Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. Schizophr Bull (2011) 1.78
Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology (2009) 1.36
¹H-[¹³C]-nuclear magnetic resonance spectroscopy measures of ketamine's effect on amino acid neurotransmitter metabolism. Biol Psychiatry (2011) 1.14
An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression. Int J Neuropsychopharmacol (2011) 0.97
Relationship between genetic variation in the glutaminase gene GLS1 and brain glutamine/glutamate ratio measured in vivo. Biol Psychiatry (2011) 0.91
Cortical metabolites as biomarkers in the R6/2 model of Huntington's disease. J Cereb Blood Flow Metab (2011) 0.91
The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia. BMC Res Notes (2012) 0.89
Relationship among Glutamine, γ-Aminobutyric Acid, and Social Cognition in Autism Spectrum Disorders. J Child Adolesc Psychopharmacol (2015) 0.88
Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects. Mol Psychiatry (2016) 0.86
Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis. Front Psychiatry (2013) 0.86
Metabolic Flux and Compartmentation Analysis in the Brain In vivo. Front Endocrinol (Lausanne) (2013) 0.85
Glutamate-mediated excitotoxicity in schizophrenia: a review. Eur Neuropsychopharmacol (2014) 0.84
Molecular substrates of schizophrenia: homeostatic signaling to connectivity. Mol Psychiatry (2015) 0.82
An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive-Compulsive Disorder. Neuropsychopharmacology (2015) 0.82
Neuropharmacological and neurobiological relevance of in vivo ¹H-MRS of GABA and glutamate for preclinical drug discovery in mental disorders. Neuropsychopharmacology (2014) 0.79
Animal models and high field imaging and spectroscopy. Dialogues Clin Neurosci (2013) 0.79
Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders. Bioanalysis (2012) 0.78
Frontal P3 event-related potential is related to brain glutamine/glutamate ratio measured in vivo. Neuroimage (2015) 0.78
Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A (1)H-MRS and pCASL study. Neuropsychopharmacology (2016) 0.77
Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. Drug Alcohol Depend (2015) 0.77
In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T. Schizophr Bull (2013) 0.76
Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities. Neuropsychopharmacology (2016) 0.76
Preclinical Magnetic Resonance Imaging and Spectroscopy Studies of Memory, Aging, and Cognitive Decline. Front Aging Neurosci (2016) 0.75
Glutamate carboxypeptidase II and folate deficiencies result in reciprocal protection against cognitive and social deficits in mice: implications for neurodevelopmental disorders. Dev Neurobiol (2012) 0.75
Simultaneous measurement of glucose blood-brain transport constants and metabolic rate in rat brain using in-vivo 1H MRS. J Cereb Blood Flow Metab (2012) 0.75
Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry (1991) 8.10
Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci (1997) 5.30
NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res (2000) 4.66
Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol (2006) 4.60
NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci (2007) 4.35
In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med (1999) 4.26
The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology (1999) 3.78
Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science (1998) 3.70
Field mapping without reference scan using asymmetric echo-planar techniques. Magn Reson Med (2000) 3.13
Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science (1989) 2.77
Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol (2006) 2.73
Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci (2003) 2.43
Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. J Magn Reson (1999) 2.42
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl) (2003) 2.28
Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry (2002) 2.20
Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol (2001) 2.12
Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am J Psychiatry (2005) 1.84
Animal behavior models of the mechanisms underlying antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry (2003) 1.62
Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry (2008) 1.58
The GABA-glutamate connection in schizophrenia: which is the proximate cause? Biochem Pharmacol (2004) 1.57
First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients. Mol Psychiatry (2006) 1.49
Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy. J Neurochem (2007) 1.38
Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia. Arch Gen Psychiatry (2002) 1.34
Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch Gen Psychiatry (1997) 1.28
Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine. Neuropsychopharmacology (2003) 1.22
Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice. Neuropsychopharmacology (2000) 1.09
The NMDA receptor hypofunction model of psychosis. Ann N Y Acad Sci (2003) 1.09
Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists. Neuropsychopharmacology (2004) 1.09
Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. Eur Neuropsychopharmacol (2008) 1.06
Glial-neuronal interactions are impaired in the schizophrenia model of repeated MK801 exposure. Neuropsychopharmacology (2005) 1.00
Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients. Psychophysiology (1998) 1.00
Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenics. J Nucl Med (1997) 0.98
Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet (1997) 0.98
Isoflurane strongly affects the diffusion of intracellular metabolites, as shown by 1H nuclear magnetic resonance spectroscopy of the monkey brain. J Cereb Blood Flow Metab (2006) 0.97
Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex. Biol Psychiatry (2001) 0.95
Metabolic changes in quinolinic acid-lesioned rat striatum detected non-invasively by in vivo (1)H NMR spectroscopy. J Neurosci Res (2001) 0.94
Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia. Psychopharmacology (Berl) (2005) 0.92
Alterations in local cerebral glucose utilization induced by phencyclidine. Brain Res (1987) 0.90
Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence. Psychopharmacology (Berl) (1998) 0.89
Delayed regional metabolic actions of phencyclidine. Eur J Pharmacol (1993) 0.89
Nitric oxide signaling in the medial prefrontal cortex is involved in the biochemical and behavioral effects of phencyclidine. Neuropsychopharmacology (2007) 0.89
Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.87
High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients. Am J Psychiatry (1995) 0.83
Acute increase of the glutamate-glutamine cycling in discrete brain areas after administration of a single dose of amphetamine. Ann N Y Acad Sci (2008) 0.81
Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat. Behav Brain Res (2005) 0.81
Impaired glutamine metabolism in NMDA receptor hypofunction induced by MK801. J Neurochem (2005) 0.80
PCP-induced alterations in cerebral glucose utilization in rat brain: blockade by metaphit, a PCP-receptor-acylating agent. Synapse (1987) 0.80
Cerebral metabolic changes induced by MK-801: a 1D (phosphorus and proton) and 2D (proton) in vivo NMR spectroscopy study. Brain Res (1994) 0.79
Impaired neuronal glucose uptake in pathogenesis of schizophrenia - can GLUT 1 and GLUT 3 deficits explain imaging, post-mortem and pharmacological findings? Med Hypotheses (2005) 0.78
Regional alterations in brain amino acids after administration of the N-methyl-D-aspartate receptor antagonists MK-801 and CGP 39551 in rats. Neurosci Lett (1991) 0.78
Mitochondrial activity in the mapping of functional brain changes in schizophrenia. Restor Neurol Neurosci (1998) 0.77
Multiplexed echo planar imaging for sub-second whole brain FMRI and fast diffusion imaging. PLoS One (2010) 5.74
The WU-Minn Human Connectome Project: an overview. Neuroimage (2013) 5.49
beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem (2005) 4.91
Temporally-independent functional modes of spontaneous brain activity. Proc Natl Acad Sci U S A (2012) 4.44
Sustained negative BOLD, blood flow and oxygen consumption response and its coupling to the positive response in the human brain. Neuron (2002) 3.92
Reconstruction of the orientation distribution function in single- and multiple-shell q-ball imaging within constant solid angle. Magn Reson Med (2010) 3.24
Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo. Magn Reson Med (2007) 3.23
Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J Biol Chem (2006) 3.00
9.4T human MRI: preliminary results. Magn Reson Med (2006) 2.98
Local B1+ shimming for prostate imaging with transceiver arrays at 7T based on subject-dependent transmit phase measurements. Magn Reson Med (2008) 2.78
Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans. Ann Neurol (2004) 2.74
Effect of basal conditions on the magnitude and dynamics of the blood oxygenation level-dependent fMRI response. J Cereb Blood Flow Metab (2002) 2.72
Analysis of fMRI and finger tracking training in subjects with chronic stroke. Brain (2002) 2.67
Test-retest and between-site reliability in a multicenter fMRI study. Hum Brain Mapp (2008) 2.63
Analysis of wave behavior in lossy dielectric samples at high field. Magn Reson Med (2002) 2.59
Distinct basal ganglia territories are engaged in early and advanced motor sequence learning. Proc Natl Acad Sci U S A (2005) 2.57
Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry (2008) 2.53
Standard magnetic resonance-based measurements of the Pi→ATP rate do not index the rate of oxidative phosphorylation in cardiac and skeletal muscles. Am J Physiol Cell Physiol (2011) 2.53
Advances in diffusion MRI acquisition and processing in the Human Connectome Project. Neuroimage (2013) 2.46
Correction of physiologically induced global off-resonance effects in dynamic echo-planar and spiral functional imaging. Magn Reson Med (2002) 2.42
Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference. Proc Natl Acad Sci U S A (2003) 2.40
Mirror-symmetric tonotopic maps in human primary auditory cortex. Neuron (2003) 2.39
High-resolution, spin-echo BOLD, and CBF fMRI at 4 and 7 T. Magn Reson Med (2002) 2.31
Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Science (2003) 2.31
Dysregulation of working memory and default-mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC study. Hum Brain Mapp (2009) 2.28
Early-stage visual processing and cortical amplification deficits in schizophrenia. Arch Gen Psychiatry (2005) 2.25
Highly resolved in vivo 1H NMR spectroscopy of the mouse brain at 9.4 T. Magn Reson Med (2004) 2.25
Parallel imaging performance as a function of field strength--an experimental investigation using electrodynamic scaling. Magn Reson Med (2004) 2.22
Sex differences in learning in chimpanzees. Nature (2004) 2.22
Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2. Science (2004) 2.19
Whole-body imaging at 7T: preliminary results. Magn Reson Med (2009) 2.13
Public health preparedness: evolution or revolution? Health Aff (Millwood) (2006) 2.12
In vivo 31P magnetic resonance spectroscopy of human brain at 7 T: an initial experience. Magn Reson Med (2003) 2.09
Proton T2 relaxation study of water, N-acetylaspartate, and creatine in human brain using Hahn and Carr-Purcell spin echoes at 4T and 7T. Magn Reson Med (2002) 2.09
Spatio-temporal point-spread function of fMRI signal in human gray matter at 7 Tesla. Neuroimage (2007) 2.07
Neuroglial metabolism in the awake rat brain: CO2 fixation increases with brain activity. J Neurosci (2004) 2.04
MRI study of white matter diffusion anisotropy in schizophrenia. Neuroreport (2003) 2.04
Race/ethnicity, income, major risk factors, and cardiovascular disease mortality. Am J Public Health (2005) 2.02
Temperature and SAR calculations for a human head within volume and surface coils at 64 and 300 MHz. J Magn Reson Imaging (2004) 2.01
Frontal white matter microstructure and treatment response of late-life depression: a preliminary study. Am J Psychiatry (2002) 2.00
TULP3 bridges the IFT-A complex and membrane phosphoinositides to promote trafficking of G protein-coupled receptors into primary cilia. Genes Dev (2010) 1.95
3-D diffusion tensor axonal tracking shows distinct SMA and pre-SMA projections to the human striatum. Cereb Cortex (2004) 1.94
Motor control in basal ganglia circuits using fMRI and brain atlas approaches. Cereb Cortex (2005) 1.93
Cortical layer-dependent BOLD and CBV responses measured by spin-echo and gradient-echo fMRI: insights into hemodynamic regulation. Neuroimage (2006) 1.90
Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies. J Magn Reson Imaging (2012) 1.86
Development of (17)O NMR approach for fast imaging of cerebral metabolic rate of oxygen in rat brain at high field. Proc Natl Acad Sci U S A (2002) 1.85
Visual inspection of independent components: defining a procedure for artifact removal from fMRI data. J Neurosci Methods (2010) 1.84
Altered resting state complexity in schizophrenia. Neuroimage (2011) 1.81
Altered functional and anatomical connectivity in schizophrenia. Schizophr Bull (2009) 1.79
Advances in white matter imaging: a review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging. Neurosci Biobehav Rev (2006) 1.77
A preliminary study of functional connectivity in comorbid adolescent depression. Neurosci Lett (2009) 1.74
Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes (2008) 1.74
White matter integrity predicts delay discounting behavior in 9- to 23-year-olds: a diffusion tensor imaging study. J Cogn Neurosci (2009) 1.72
Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia. Neuropsychopharmacology (2007) 1.70
Depressive symptoms and mortality in men: results from the Multiple Risk Factor Intervention Trial. Stroke (2004) 1.68
Combined imaging-histological study of cortical laminar specificity of fMRI signals. Neuroimage (2005) 1.67
Respiration-induced B0 fluctuations and their spatial distribution in the human brain at 7 Tesla. Magn Reson Med (2002) 1.67
Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study. Heart Rhythm (2011) 1.64
T1rho MRI contrast in the human brain: modulation of the longitudinal rotating frame relaxation shutter-speed during an adiabatic RF pulse. J Magn Reson (2006) 1.64
S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. Mol Cell (2008) 1.63
Provider factors associated with intramedullary nail use for intertrochanteric hip fractures. J Bone Joint Surg Am (2010) 1.62
Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary study. Biol Psychiatry (2002) 1.62
The neural substrates of impaired prosodic detection in schizophrenia and its sensorial antecedents. Am J Psychiatry (2007) 1.61
Diffusion tensor imaging in psychiatric disorders. Top Magn Reson Imaging (2008) 1.60
Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts. Mov Disord (2007) 1.60
White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. Am J Psychiatry (2005) 1.56
A microstrip transmission line volume coil for human head MR imaging at 4T. J Magn Reson (2003) 1.56
Localized in vivo 13C NMR spectroscopy of the brain. NMR Biomed (2003) 1.55
Spatially constrained hierarchical parcellation of the brain with resting-state fMRI. Neuroimage (2013) 1.55
Diffusion tensor imaging of frontal white matter microstructure in early Alzheimer's disease: a preliminary study. J Geriatr Psychiatry Neurol (2005) 1.54
Potential and feasibility of parallel MRI at high field. NMR Biomed (2006) 1.54
Associations of smoking prevalence with individual and area level social cohesion. J Epidemiol Community Health (2004) 1.53
Proton echo-planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4 Tesla. Magn Reson Med (2007) 1.53
ZIP-code-based versus tract-based income measures as long-term risk-adjusted mortality predictors. Am J Epidemiol (2006) 1.53
Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults. Clin Infect Dis (2010) 1.52
Altered white matter microstructure in adolescents with major depression: a preliminary study. J Am Acad Child Adolesc Psychiatry (2010) 1.52
Transverse relaxation in the rotating frame induced by chemical exchange. J Magn Reson (2004) 1.52
In vivo 1H2O T2+ measurement in the human occipital lobe at 4T and 7T by Carr-Purcell MRI: detection of microscopic susceptibility contrast. Magn Reson Med (2002) 1.52
Functional magnetic resonance imaging of the retina. Invest Ophthalmol Vis Sci (2002) 1.51
Oxidative capacity in failing hearts. Am J Physiol Heart Circ Physiol (2003) 1.51
Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra. Magn Reson Med (2003) 1.49
White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study. Arch Gen Psychiatry (2005) 1.49
Functional connectivity in the cognitive control network and the default mode network in late-life depression. J Affect Disord (2012) 1.48
Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (2005) 1.47
Measurement of unidirectional Pi to ATP flux in human visual cortex at 7 T by using in vivo 31P magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (2003) 1.47
Metabolic and hemodynamic events after changes in neuronal activity: current hypotheses, theoretical predictions and in vivo NMR experimental findings. J Cereb Blood Flow Metab (2008) 1.47
Neurocognitive and neuroimaging correlates of pediatric traumatic brain injury: a diffusion tensor imaging (DTI) study. Arch Clin Neuropsychol (2007) 1.47
Adaptive mechanisms regulate preferred utilization of ketones in the heart and brain of a hibernating mammal during arousal from torpor. Am J Physiol Regul Integr Comp Physiol (2008) 1.45
The development of corpus callosum microstructure and associations with bimanual task performance in healthy adolescents. Neuroimage (2007) 1.43
Non-invasive detection of neurochemical changes prior to overt pathology in a mouse model of spinocerebellar ataxia type 1. J Neurochem (2013) 1.43
An inverted-microstrip resonator for human head proton MR imaging at 7 tesla. IEEE Trans Biomed Eng (2005) 1.41
DTI and impulsivity in schizophrenia: a first voxelwise correlational analysis. Neuroreport (2004) 1.38
Diffusion tensor imaging in fixed brain tissue at 7.0 T. NMR Biomed (2003) 1.38
Tuning in to the voices: a multisite FMRI study of auditory hallucinations. Schizophr Bull (2008) 1.38
Mechanisms underlying decoding at 7 T: ocular dominance columns, broad structures, and macroscopic blood vessels in V1 convey information on the stimulated eye. Neuroimage (2009) 1.38
Body size and predatory performance in wolves: is bigger better? J Anim Ecol (2009) 1.36
An assessment of current brain targets for deep brain stimulation surgery with susceptibility-weighted imaging at 7 tesla. Neurosurgery (2010) 1.36
Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry (2004) 1.35